Linda Yaccarino Joins Health Tech Platform Emed As Ceo After Leaving X

Linda Yaccarino’s adjacent domiciled aft departing X arsenic CEO will beryllium different main executive domiciled astatine eMed Population Health, an AI startup building a tech level for patients utilizing GLP-1s.

Yaccarino was a longtime advertizing executive astatine NBCUniversal, but near to subordinate X arsenic CEO for 2 years, wherever she managed to person a positive impact connected nan societal network’s troubled advertisement gross model, contempt her and Elon Musk’s shared attack to minimizing contented moderation.

Though Yaccarino does not person acquisition successful wellness tech, eMed said successful a property merchandise that they sought her retired for her “undeniable expertise to discuss caller partnerships” — it surely besides helps that her tenure astatine X made her well-known successful nan tech world, drafting much eyes toward nan startup.

eMed previously produced a tech level that was designed to beryllium utilized pinch at-home COVID-19 accelerated antigen tests, guiding users done nan process of administering these tests properly. Now, eMed is focused connected GLP-1s, nan people of narcotics for illustration Ozempic, which tin beryllium utilized for some weight guidance and curen of type II diabetes.

“To beryllium a leader successful today’s healthcare marketplace, companies request to person a fearless tenacity that allows them to not only grow, but to besides beryllium brave capable to measurement guardant and redefine an full industry,” Yaccarino said successful a property release. “We are very well-positioned to beryllium that tenacious leader, striving toward our eventual extremity of improving world healthcare outcomes done our groundbreaking services and platforms.”